These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 36453542)

  • 1. Advances in Lipid-Based Codelivery Systems for Cancer and Inflammatory Diseases.
    Jogdeo CM; Panja S; Kanvinde S; Kapoor E; Siddhanta K; Oupický D
    Adv Healthc Mater; 2023 Mar; 12(7):e2202400. PubMed ID: 36453542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
    Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
    Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy.
    Yadav P; Dua C; Bajaj A
    Chem Rec; 2022 Dec; 22(12):e202200152. PubMed ID: 36103616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
    Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
    J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel formulation approaches for synergistic codelivery based on lipid nanocarriers.
    Lages EB; Marques Borges GS; Miranda Ferreira LA
    Nanomedicine (Lond); 2023 Mar; 18(7):579-582. PubMed ID: 37165953
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease.
    Teng C; Lin C; Huang F; Xing X; Chen S; Ye L; Azevedo HS; Xu C; Wu Z; Chen Z; He W
    Acta Pharm Sin B; 2020 Aug; 10(8):1521-1533. PubMed ID: 32963947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance.
    Gong J; Shi T; Liu J; Pei Z; Liu J; Ren X; Li F; Qiu F
    Biomed Pharmacother; 2023 May; 161():114505. PubMed ID: 36921532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.
    Hanafi-Bojd MY; Ansari L; Malaekeh-Nikouei B
    Ther Deliv; 2016 Sep; 7(9):649-55. PubMed ID: 27582236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanoparticle-mediated combining therapy for human diseases.
    Li X; Peng X; Zoulikha M; Boafo GF; Magar KT; Ju Y; He W
    Signal Transduct Target Ther; 2024 Jan; 9(1):1. PubMed ID: 38161204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells.
    Younis MA; Khalil IA; Abd Elwakil MM; Harashima H
    Mol Pharm; 2019 Sep; 16(9):4031-4044. PubMed ID: 31403802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and latest advances of codelivery systems for cancer therapy.
    Meng QY; Cong HL; Hu H; Xu FJ
    Mater Today Bio; 2020 Jun; 7():100056. PubMed ID: 32510051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
    J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insights into the development of nucleic acid-based nanoparticles for tumor-targeted drug delivery.
    Buddolla AL; Kim S
    Colloids Surf B Biointerfaces; 2018 Dec; 172():315-322. PubMed ID: 30176511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy.
    Li T; Shen X; Geng Y; Chen Z; Li L; Li S; Yang H; Wu C; Zeng H; Liu Y
    ACS Appl Mater Interfaces; 2016 Jun; 8(22):13748-58. PubMed ID: 27191965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment.
    Gaspar R; Coelho F; Silva BFB
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Indocyanine Green-Based Codelivery Nanoplatforms for Combinatorial Therapy.
    Xu PY; Zheng X; Kankala RK; Wang SB; Chen AZ
    ACS Biomater Sci Eng; 2021 Mar; 7(3):939-962. PubMed ID: 33539071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-Responsive Codelivery System Self-Assembled from
    Wu X; Zhang D; Pan T; Li J; Xie Y; Zhang C; Pan C; Zhang Z; Lin J; Wu A; Shao G
    ACS Appl Mater Interfaces; 2023 Sep; 15(38):44773-44785. PubMed ID: 37721368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.